Descriptor English: | Doripenem | ||||||
Descriptor Spanish: |
Doripenem
| ||||||
Descriptor Portuguese: | Doripenem | ||||||
Descriptor French: | Doripénem | ||||||
Entry term(s): |
2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid S 4661 S-4661 S4661 |
||||||
Tree number(s): |
D02.065.589.099.124.150 D03.633.100.300.124.150 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077726 | ||||||
Scope note: | A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents |
||||||
Registry Number: | BHV525JOBH | ||||||
CAS Type 1 Name: | 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)- | ||||||
Public MeSH Note: | 2019; DORIPENEM was indexed under CARBAPENEMS 1996-2018 |
||||||
History Note: | 2019 (1996) |
||||||
DeCS ID: | 57733 | ||||||
Unique ID: | D000077726 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/10 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Doripenem
- Preferred
2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid
- Narrower
S 4661
- Narrower
Concept UI |
M0260551 |
Scope note | A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS. |
Preferred term | Doripenem |
Concept UI |
M000641382 |
Preferred term | 2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid |
Concept UI |
M0472565 |
Preferred term | S 4661 |
Entry term(s) |
S-4661 S4661 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey